Transdermal bioidentical estradiol may carry a lower risk of clotting than oral forms because it avoids first-pass liver

https://giphy.com/channel/celeifsddv

Transdermal bioidentical estradiol may carry a lower risk of clotting than oral forms because it avoids first-pass liver metabolism, potentially making it preferable for some high-risk patients.